Olofast Nasal Spray
By Olofast
Rx
12ml Nasal Spray in a Packet

Composition
Olopatadine(0.6% w/v)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
October, 2025

liver
It has been indicated that no known interactions have been found or established between Olofast Nasal Spray and the liver. This suggests that there are currently no specific safety concerns or advice related to liver issues in relation to the use of this nasal spray. It is always essential to be cautious and consult with your doctor for proper guidance before using Olofast Nasal Spray to ensure its safe use for individuals with any liver-related conditions.

kidney
No interaction has been found or established between Olofast Nasal Spray and kidney issues.

alcohol
No interaction with alcohol has been found or established for Olofast Nasal Spray. It is important to consult your doctor if you are pregnant before using this product.

driving
When using Olofast Nasal Spray, there are no established interactions that affect driving. It is safe to drive while using this product.

pregnancy
Olofast Nasal Spray may not be safe to use during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor before using.

breastfeeding
Regarding safety advice for breastfeeding while using Olofast Nasal Spray, limited human data indicates that it is likely safe with no significant risk to the baby.
Habit Forming | No |
Chemical Class | Dibenzoxepine Derivative |
Therapeutic Class | - |
Action Class | H1 Antihistaminics (second Generation) |
₹260
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025